Company intelligence / Profile preview

Tenovi

Portsmouth, New Hampshire, United States

Ownership: Private
Development stage: Other

Overview

Over 40 FDA-cleared remote monitoring devices deployed via the Tenovi platform, serving 250,000 patients as of August 2025 with significant revenue growth and broad adoption in clinical RPM/RTM programs.

Therapeutic areas: CardiovascularEndocrinologyWomen's HealthPulmonologyOther
Modalities: Devicecellular-connected medical devicesIoT-enabled RPM/RTM devices
Industry: Physiological Monitoring

Partnerships

GenieMD (virtual chronic disease care platform)Circadian Health (virtual-first specialty care in cardiometabolic diseases)Rimidi (chronic disease management platform)ChronicCareIQ (care management provider)

Beyond the preview

Go deeper on Tenovi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tenovi.

Explore the full profile